Biomarkers, Risk Factors, and Risk: Clarifying the Controversy About Surrogate End Points and Clinical Outcomes.

Authors :: Krumholz HM
Source :: Circulation. Cardiovascular quality and outcomes [Circ Cardiovasc Qual Outcomes] 2015 Sep; Vol. 8 (5), pp. 457-9.
Publication Year :: 2015

Subjects :: Humans
Morbidity
Risk Factors
United States epidemiology
Biomarkers analysis
Cardiovascular Diseases epidemiology
Cardiovascular Diseases metabolism
Cardiovascular Diseases therapy
Disease Management
Endpoint Determination methods
Risk Assessment

Full Text Access

Tools